Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0V9PB
|
|||
| Drug Name |
Gilotrifafatinib
|
|||
| Indication | Lung squamous cell carcinoma [ICD-11: 2C25.2] | Phase 2 | [1] | |
| Rhabdomyosarcoma [ICD-11: 2B55; ICD-9: 171] | Phase 1/2 | [1] | ||
| Company |
Boehringer Ingelheim Pharmaceuticals Ridgefield, CT
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.